Tarsons Products has received approval to make investments of up to maximum 13 million euros in Tarsons Life Science, a subsidiary of the company, either by the way of subscription to the shares or through paying the existing loans. Purpose of investments is to provide loan for business purposes to the subsidiary. The Board of Directors of the company at its meeting held on December 12, 2023, have inter alia considered and approved the same.
The company presently manufactures disposable plastic labware, centrifuge ware, cryo labware, liquid handling system and instruments.